These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25963090)
41. Irinotecan and other agents in upper gastrointestinal and colorectal carcinomas. The University of Texas M. D. Anderson Cancer Center Investigators' Workshop, Volume 3. Introduction. Ajani JA Oncology (Williston Park); 2003 Sep; 17(9 Suppl 8):10-2. PubMed ID: 14569840 [No Abstract] [Full Text] [Related]
46. Progress with biological agents in metastatic colorectal cancer leads to many challenges. Van Cutsem E J Clin Oncol; 2006 Jul; 24(21):3325-7. PubMed ID: 16849745 [No Abstract] [Full Text] [Related]
48. S-1: another oral agent for patients with colorectal cancer. Benson AB Lancet Oncol; 2013 Dec; 14(13):1244-5. PubMed ID: 24225156 [No Abstract] [Full Text] [Related]
49. When less is more: maintenance therapy in colorectal cancer. Hubbard JM; Grothey A Lancet; 2015 May; 385(9980):1808-10. PubMed ID: 25862518 [No Abstract] [Full Text] [Related]
50. Therapeutic strategies for colorectal cancer in Europe and the United States: focus on chemotherapy for advanced colorectal cancer. Bennouna J; Douillard JY Int J Clin Oncol; 2002 Aug; 7(4):236-44. PubMed ID: 12202977 [No Abstract] [Full Text] [Related]
52. [Problems of randomized controlled study on surgical adjuvant chemotherapy for colorectal cancer in Japan]. Kodaira S Gan To Kagaku Ryoho; 1993 Dec; 20(16):2461-6. PubMed ID: 8279842 [TBL] [Abstract][Full Text] [Related]
54. Costs of chemotherapy in the treatment of colorectal cancer. Jansman FG; Postma MJ Eur J Health Econ; 2006 Jun; 7(2):145-6. PubMed ID: 16699776 [No Abstract] [Full Text] [Related]
55. Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis. Ilic I; Jankovic S; Ilic M PLoS One; 2016; 11(8):e0161912. PubMed ID: 27579775 [TBL] [Abstract][Full Text] [Related]
56. The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials. Giuliani J; Bonetti A Clin Colorectal Cancer; 2016 Dec; 15(4):277-284. PubMed ID: 27521066 [TBL] [Abstract][Full Text] [Related]